Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI agents are powerful, but without a strong control plane and hard guardrails, they’re just one bad decision away from chaos.

Print Join the Discussion View in the ACM Digital Library The mathematical reasoning performed by LLMs is fundamentally different from the rule-based symbolic methods in traditional formal reasoning.

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...